RESUMO
Abstract Pheretima posthuma (Vaillant, 1868), a native earthworm of Pakistan and Southeast Asia, has wide utilization in vermicomposting and bioremediation process. In this study, P. posthuma coelomic fluid (PCF) and body paste (PBP) was evaluated as antibacterial agent against ampicillin (AMP) resistant five Gram positive and four Gram negative clinical isolates. The antibacterial effect of different doses (i.e. 25-100 µg/ml) of PCF and PBP along with AMP and azithromycin (AZM) (negative and positive controls, respectively) were observed through disc diffusion and micro-dilution methods. All nine clinical isolates were noticed as AMP resistant and AZM sensitive. Antibacterial effects of PCF and PBP were dose dependent and zone of inhibitions (ZI) against all clinical isolates were between 23.4 ± 0.92 to 0 ± 00 mm. The sensitivity profile of PCF and PBP against clinical isolates was noticed as 44.44 and 55.56%, respectively. Both PCF and PBP showed bacteriostatic (BTS) action against S. aureus, S. pyogenes, K. pneumonia, N. gonorrhoeae. Moreover, the cumulative BTS potential of PCF and PBP against all isolates was 66.67 and 55.56%, respectively. The MICs of PCF and PBP were ranged from 50-200 µg/ml against selected isolates. The bacterial growth curves indicated that PCF and PBP inhibited the growth of all isolates at their specific MIC concentrations. However, PBP has better antibacterial potential compared to PCF against selected isolates. Therefore, it is concluded that both PCF and PBP of P. posthuma possess antibacterial and BTS potential against ampicillin resistant clinical isolates. This organism might be considered as a second choice of antibacterial agents and can further be utilized in pharmaceutical industries for novel drug manufacturing by prospecting bioactive potential agents.
Resumo Pheretima posthuma (Vaillant, 1868), uma minhoca nativa do Paquistão e sudeste da Ásia, tem ampla utilização em processos de vermicompostagem e biorremediação. Neste estudo, o fluido celômico de P. posthuma (PCF) e a pasta corporal (PBP) foram avaliados como agente antibacteriano contra cinco isolados clínicos Gram-positivos e quatro Gram-negativos resistentes à ampicilina (AMP). O efeito antibacteriano de diferentes doses (ou seja, 25-100 µg / ml) de PCF e PBP juntamente com AMP e azitromicina (AZM) (controles negativo e positivo, respectivamente) foi observado por meio de métodos de difusão em disco e microdiluição. Todos os nove isolados clínicos foram notados como resistentes a AMP e sensíveis a AZM. Os efeitos antibacterianos de PCF e PBP foram dependentes da dose e a zona de inibição (ZI) contra todos os isolados clínicos foi entre 23,4 ± 0,92 a 0 ± 00 mm. O perfil de sensibilidade do PCF e PBP contra isolados clínicos foi observado como 44,44% e 55,56%, respectivamente. Tanto o PCF quanto o PBP mostraram ação bacteriostática (BTS) contra S. aureus, S. pyogenes, K. pneumonia, N. gonorrhoeae. Além disso, o potencial BTS cumulativo de PCF e PBP contra todos os isolados foi de 66,67% e 55,56%, respectivamente. Os MICs de PCF e PBP variaram de 50-200 µg / ml contra isolados selecionados. As curvas de crescimento bacteriano indicaram que o PCF e o PBP inibiram o crescimento de todos os isolados em suas concentrações específicas de MIC. No entanto, PBP tem melhor potencial antibacteriano em comparação com PCF contra isolados selecionados. Portanto, conclui-se que tanto o PCF quanto o PBP de P. posthuma possuem potencial antibacteriano e BTS contra isolados clínicos resistentes à ampicilina. Esse organismo pode ser considerado como uma segunda escolha de agentes antibacterianos e pode ainda ser utilizado nas indústrias farmacêuticas para a fabricação de novos medicamentos por meio da prospecção de agentes com potencial bioativo.
Assuntos
Animais , Oligoquetos , Staphylococcus aureus , Testes de Sensibilidade Microbiana , Ampicilina/farmacologia , Antibacterianos/farmacologiaRESUMO
Se evaluó la actividad in vitro de la asociación entre ampicilina y ceftriaxona frente a 30 aislamientos de Enterococcus faecalis obtenidos de infecciones invasivas de pacientes atendidos en el Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires. Las sinergias entre ampicilina y ceftriaxona se determinaron mediante la técnica de dilución en caldo Müeller-Hinton con el agregado de diferentes concentraciones subinhibitorias de ceftriaxona o sin este. La asociación fue sinérgica en 22/30 aislamientos. En 14/30 aislamientos la asociación disminuyó los valores de concentración inhibitoria mínima (CIM) y de concentración bactericida mínima (CBM); en 6/30 se observó solamente una disminución de la CIM, mientras que en 2 solo se determinó una reducción de la CBM. La actividad bactericida de la asociación fue mayor a bajas concentraciones de ampicilina (menor de 1µg/ml). Se demostró la sinergia in vitro entre ampicilina-ceftriaxona; se confirmó así la utilidad de esta asociación en el tratamiento de infecciones severas causadas por E. faecalis
In vitro activity of the combination of ampicillin- ceftriaxone against 30 Enterococcus faecalis isolates recovered from invasive infections in patients admitted to Hospital de Clínicas José de San Martin in the city of Buenos Aires was assessed. Ampicillin- ceftriaxone synergies were determined by microdilution in Müeller-Hinton (MH) broth with and without subinhibitory concentrations of ceftriaxone. Synergy was detected in 22/30 isolates. A decrease in both minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) was observed in 14/30 isolates, whereas in 6/30 isolates the decrease was observed in the MIC value and only in the MBC value in the 2 remaining isolates. The bactericidal activity of the combination showed to be higher at low concentrations of ampicillin (< 1µg/ml). We detected in vitro synergy using the ampicillin-ceftriaxone combination and thus, its efficacy was confirmed in the treatment of severe infections by E. faecalis
Assuntos
Humanos , Masculino , Feminino , Ceftriaxona/farmacologia , Testes de Sensibilidade Microbiana/estatística & dados numéricos , Enterococcus faecalis/isolamento & purificação , Ampicilina/farmacologia , Antibacterianos/análise , Infecções Bacterianas/tratamento farmacológico , Técnicas In Vitro/métodos , Sinergismo FarmacológicoRESUMO
OBJECTIVES: To describe a new approach for the application of polymethylmethacrylate augmentation of bone cement-injectable cannulated pedicle screws. METHODS: Between June 2010 and February 2013, 43 patients with degenerative spinal disease and osteoporosis (T-score <-2.5) underwent lumbar fusion using cement-injectable cannulated pedicle screws. Clinical outcomes were evaluated using a Visual Analog Scale and the Oswestry Disability Index. Patients were given radiographic follow-up examinations after 3, 6, and 12 months and once per year thereafter. RESULTS: All patients were followed for a mean of 15.7±5.6 months (range, 6 to 35 months). The Visual Analog Scale and Oswestry Disability Index scores showed a significant reduction in back pain (p = 0.018) and an improvement in lower extremity function (p = 0.025) in patients who underwent lumbar fusion using the novel screw. Intraoperative cement leakage occurred in four patients, but no neurological complications were observed. Radiological observation indicated no loosening or pulling out of the novel screw, and bone fusion was excellent. CONCLUSIONS: The described polymethylmethacrylate augmentation technique using bone cement-injectable cannulated pedicle screws can reduce pain and improve spinal dysfunction in osteoporotic patients undergoing osteoporotic spine surgery. .
Assuntos
Antibacterianos/farmacologia , Ciprofloxacina/farmacologia , Salmonella typhi/efeitos dos fármacos , Ampicilina/farmacologia , Farmacorresistência Bacteriana , Fluoroquinolonas/farmacologia , Índia , Testes de Sensibilidade Microbiana , Combinação Trimetoprima e Sulfametoxazol/farmacologiaRESUMO
Introducción . Los microorganismos patógenos como Enterobacter cloacae producen betalactamasas que les confieren resistencia frente a los antibióticos betalactámicos; se ha identificado, además, la actividad limitada de los inhibidores enzimáticos, de modo que la única posibilidad de enfrentar la resistencia es el diseño de nuevos fármacos y su uso racional. Objetivo. Evaluar el efecto de la chalcona dihidroxifenil propenona sobre un aislamiento clínico de E. cloacae y sobre la betalactamasa aislada a partir de este microorganismo resistente como un aporte en la búsqueda de compuestos inhibidores de las betalactamasas. Materiales y métodos. Se sintetizó la chalcona dihidroxifenil propenona y se evaluó su efecto sobre el aislamiento clínico de E. cloacae para determinar la concentración inhibitoria mínima mediante el método de microdilución en caldo y con la betalactamasa purificada mediante cromatografía de afinidad se realizaron estudios espectrofotométricos de cinética enzimática. Resultados. La concentración inhibitoria mínima de la dihidroxifenil propenona sobre E. cloacae fue de 35 µg/ml; el porcentaje de recuperación de la betalactamasa a partir del microorganismo fue de 31,75 %; en el estudio cinético se evidenció actividad inhibitoria de acuerdo con los parámetros cinéticos de V max =1,7 x 10 -3 µM/minuto y K M´ =2330 µM. Conclusión. La chalcona dihidroxifenil propenona ejerce su actividad inhibitoria por medio de la interacción con la betalactamasa y, de esta manera, protege la integridad estructural de los antibióticos betalactámicos; dicho efecto sinérgico la convierte en un compuesto promisorio en la búsqueda de alternativas para enfrentar la resistencia bacteriana.
Introduction: Enterobacter cloacae is a pathogenic microorganism with the ability to produce betalactamase enzymes, which makes them resistant to betalactamic antibiotics. Additionally, the limited activity of enzymatic inhibitors has been identified, and, therefore, the design of new drugs and the promotion of their rational use are the only possibilities to overcome this problem. Objective: The aim of this research was to evaluate the effect of dihydroxy-phenyl-propenone on a clinical isolate of E. cloacae , as well as its activity on a betalactamase isolated from this resistant microorganism in order to contribute to the search for new betalactamase inhibitors. Materials and methods: Dihydroxy-phenyl-propenone chalcone was synthesized and evaluated on a clinical isolate of E. cloacae to determine the minimum inhibitory concentration by broth microdilution; once the betalactamase enzyme was purified by affinity chromatography, a spectrophotometric analysis was done to evaluate its kinetic activity. Results: The minimum inhibitory concentration value of dihydroxy-phenyl-propenone on E. cloacae was 35 µg/ml; the recovery percentage of the betalactamase from the microorganism was 31.75% and the kinetic parameters were V max =1.7 x 10 -3 µM/min and K M = 2330 µM, which show an important inhibitory activity. Conclusion: Dihydroxy-phenyl-propenone has shown inhibitory activity on betalactamase enzymes and the ability to protect the chemical integrity of betalactamic antibiotics; this synergistic effect turns it into a promising compound in the search for new alternatives to overcome bacterial resistance.
Assuntos
Humanos , Proteínas de Bactérias/antagonistas & inibidores , Chalconas/farmacologia , Enterobacter cloacae/efeitos dos fármacos , Penicilinase/metabolismo , Resistência beta-Lactâmica/efeitos dos fármacos , Inibidores de beta-Lactamases/farmacologia , Ampicilina/farmacologia , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/metabolismo , Cromatografia de Afinidade , Contagem de Colônia Microbiana , Colorimetria , Chalconas/química , Chalconas/síntese química , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Enterobacter cloacae/enzimologia , Infecções por Enterobacteriaceae/microbiologia , Testes de Sensibilidade Microbiana , Estrutura Molecular , Ácido Penicilânico/análogos & derivados , Ácido Penicilânico/antagonistas & inibidores , Penicilinase/isolamento & purificação , Inibidores de beta-Lactamases/química , Inibidores de beta-Lactamases/síntese químicaRESUMO
Diarrhoeal disease is still considered a major cause of morbidity and mortality among children. Among diarrhoeagenic agents, Shigella should be highlighted due to its prevalence and the severity of the associated disease. Here, we assessed Shigella prevalence, drug susceptibility and virulence factors. Faeces from 157 children with diarrhoea who sought treatment at the Children's Hospital João Paulo II, a reference children´s hospital in Belo Horizonte, state of Minas Gerais, Brazil, were cultured and drug susceptibility of the Shigella isolates was determined by the disk diffusion technique. Shigella virulence markers were identified by polymerase chain reaction. The bacterium was recovered from 10.8% of the children (88.2% Shigella sonnei). The ipaH, iuc, sen and ial genes were detected in strains isolated from all shigellosis patients; set1A was only detected in Shigella flexneri. Additionally, patients were infected by Shigella strains of different ial, sat, sen and set1A genotypes. Compared to previous studies, we observed a marked shift in the distribution of species from S. flexneri to S. sonnei and high rates of trimethoprim/sulfamethoxazole resistance.
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Disenteria Bacilar , Diarreia/microbiologia , Shigella/patogenicidade , Fatores de Virulência/genética , Doença Aguda , Ampicilina/farmacologia , Antibacterianos/farmacologia , Brasil/epidemiologia , Testes de Sensibilidade a Antimicrobianos por Disco-Difusão , Diarreia/prevenção & controle , Disenteria Bacilar/diagnóstico , Disenteria Bacilar/tratamento farmacológico , Disenteria Bacilar/microbiologia , Fezes/microbiologia , Genótipo , Reação em Cadeia da Polimerase , Prevalência , Shigella/classificação , Shigella/efeitos dos fármacos , Combinação Trimetoprima e Sulfametoxazol/farmacologiaRESUMO
BACKGROUND: Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with antibiotics is recommended for shigellosis, but the options are limited due to globally emerging resistance. This study was conducted to determine the frequency and pattern of antimicrobial susceptibility of Shigella in China. METHODS: We studied the antimicrobial resistance profiles of 308 Shigella spp. strains (260 S. flexneri, 40 S. sonnei, 5 S. boydii, and 3 S. dysenteriae) isolated from fecal samples of patients (age, from 3 months to 92 yr) presenting with diarrhea in different districts of Anhui, China. The antimicrobial resistance of strains was determined by the agar dilution method according to the CSLI guidelines. RESULTS: The most common serogroup in the Shigella isolates was S. flexneri (n=260, 84.4%), followed by S. sonnei (n=40, 13.0%). The highest resistance rate was found for nalidixic acid (96.4%), followed by ampicillin (93.2%), tetracycline (90.9%), and trimethoprim/sulfamethoxazole (80.8%). Among the isolates tested, 280 (91.0%) were multidrug resistant (resistant to > or =2 agents). The most common resistance pattern was the combination of ampicillin, tetracycline, and trimethoprim/sulfamethoxazole (70.8%). Resistance to ampicillin and tetracycline were more common among S. flexneri than among S. sonnei isolates. CONCLUSIONS: S. flexneri is predominant in Anhui, China, and its higher antimicrobial resistance rate compared with that of S. sonnei is a cause for concern. Continuous monitoring of resistance patterns is necessary to control the spread of resistance in Shigella. The recommendations for antimicrobial treatment must be updated regularly based on surveillance results.
Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Humanos , Lactente , Pessoa de Meia-Idade , Adulto Jovem , Ampicilina/farmacologia , Anti-Infecciosos/farmacologia , China , Farmacorresistência Bacteriana/efeitos dos fármacos , Disenteria Bacilar/diagnóstico , Fezes/microbiologia , Testes de Sensibilidade Microbiana , Ácido Nalidíxico/farmacologia , Shigella/efeitos dos fármacos , Shigella flexneri/efeitos dos fármacos , Shigella sonnei/efeitos dos fármacos , Tetraciclina/farmacologia , Fatores de Tempo , Combinação Trimetoprima e Sulfametoxazol/farmacologiaRESUMO
No abstract available.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Terapia por Acupuntura , Ampicilina/farmacologia , Tornozelo/diagnóstico por imagem , Antibacterianos/farmacologia , Celulite (Flegmão)/complicações , Diabetes Mellitus Tipo 2/complicações , Infecções por Bactérias Gram-Negativas/complicações , Hipertensão/complicações , Imageamento por Ressonância Magnética , Testes de Sensibilidade Microbiana , Prevotella nigrescens/efeitos dos fármacos , RNA Ribossômico 16S/análise , Sulbactam/farmacologia , Tomografia Computadorizada por Raios XRESUMO
OBJETIVO: Avaliar a distribuição e suscetibilidade a antimicrobianos de Shigella isolada de crianças com diarreia aguda e sem diarreia em Teresina (PI). MÉTODOS: Quatrocentas crianças com idade até 60 meses foram estudadas. Fezes foram coletadas de todos os pacientes entre janeiro de 2004 e agosto de 2007. Shigella foi identificada por métodos convencionais e antibiograma e pesquisa de β-lactamase de espectro ampliado (ESBL) foram realizados por difusão em ágar. RESULTADOS: Shigelose foi detectada apenas em crianças com diarreia aguda (26/250; 10,4%), especialmente naquelas entre 6 e 24 meses de idade e nos meses chuvosos. Shigella foi suscetível a ceftriaxona, ciprofloxacina e ácido nalidíxico. Mais da metade das amostras foram resistentes a sulfametoxazol-trimetoprim e ampicilina. ESBL não foi detectada. CONCLUSÕES: S. flexneri é comum em Teresina. A resistência a ampicilina e sulfametoxazol-trimetoprim é preocupante, pois estas drogas são amplamente utilizadas na prática e sulfametoxazol-trimetoprim ainda é recomendada para tratamento de crianças com suspeita de shigelose.
OBJECTIVE: To evaluate the distribution and susceptibility to antimicrobials of Shigella isolated from children with acute diarrhea and without diarrhea in Teresina, state of Piauí, Brazil. METHODS: Four hundred children aged up to 60 months were studied. Stools were collected from all the patients between January 2004 and August 2007. Shigella was identified by conventional methods and antibiogram and extended-spectrum β-lactamase (ESBL) were performed by agar diffusion. RESULTS: Shigellosis was only detected in children with acute diarrhea (26/250; 10.4%), especially in those aged from 6 to 24 months and in the rainy months. Shigella was susceptible to ceftriaxone, ciprofloxacin and nalidixic acid. More than half of the strains were resistant to sulphametoxazole-trimethoprim and ampicillin. ESBL was not detected. CONCLUSIONS: S. flexneri is common in Teresina. The resistance to ampicillin and sulphametoxazole-trimethoprim gives cause for concern, as these drugs are widely used in practice and sulphametoxazole-trimethoprim is also recommended for treating children suspected of having shigellosis.
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Antibacterianos/farmacologia , Resistência Microbiana a Medicamentos , Diarreia/microbiologia , Fezes/microbiologia , Shigella flexneri/efeitos dos fármacos , Shigella sonnei/efeitos dos fármacos , Doença Aguda , Ampicilina/farmacologia , Brasil , Diarreia/tratamento farmacológico , Métodos Epidemiológicos , Combinação Trimetoprima e Sulfametoxazol/farmacologia , beta-Lactamases/biossínteseRESUMO
Changes in udder health and antibiotic resistance of mastitis pathogens isolated from dairies upon conversion from conventional to organic management over a 3-year period was studied. Coagulase-negative staphylococci (CNS) were the most prevalent mastitis pathogens isolated. CNS were significantly less resistant to beta-lactam antibiotics when isolated from milk after the herd transitioned to organic management. Cessation of the use of antimicrobial therapies in dairies in combination with organic management could lead to a reduction in the antimicrobial resistance of mastitis pathogens.
Assuntos
Animais , Bovinos , Feminino , Ampicilina/farmacologia , Antibacterianos/farmacologia , Cefalotina/farmacologia , Cloxacilina/farmacologia , Resistência Microbiana a Medicamentos , Lactação , Mastite Bovina/microbiologia , Testes de Sensibilidade Microbiana , Agricultura Orgânica , Penicilinas/farmacologia , Prevalência , Infecções Estafilocócicas/microbiologia , Staphylococcus/efeitos dos fármacosRESUMO
We investigated the risk factors for resistance to ciprofloxacin, cefazolin, ampicillin and co-trimoxazole in Escherichia coli isolates from urine of Korean female patients with acute uncomplicated cystitis (AUC). A total of 225 patients and their E. coli isolates were prospectively and nationwidely enrolled between May and October, 2006. All the antimicrobials did not show any differences according to the age group. A higher rate of ciprofloxacin resistance was observed in the south (OR: 3.04, 95% CI: 1.19-7.80 for Chungcheong-do & Jeolla-do; OR: 3.04, 95% CI: 1.22-7.58 for Gyeongsang-do) compared to Gyeonggi-do. Two recurrences of AUC in the past year was an important risk factor for antimicrobial resistance (ciprofloxacin; OR: 6.71, 95% CI: 1.86-24.11 and cefazolin; OR: 5.72, 95% CI: 1.20-27.25). However, the resistance to co-trimoxazole and ampicillin was not associated with any of the risk factors. This study also revealed the pattern of multi-drugs resistance in ciprofloxacin resistant E. coli strains. In conclusion, for Korean patients with two more recurrences of AUC in the past year, it is strongly recommended to perform an antimicrobial sensitivity test with a urine sample before empirical treatment.
Assuntos
Adolescente , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Doença Aguda , Ampicilina/farmacologia , Antibacterianos/farmacologia , Cefazolina/farmacologia , Ciprofloxacina/farmacologia , Cistite/microbiologia , Farmacorresistência Bacteriana , Escherichia coli/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Estudos Prospectivos , República da Coreia , Fatores de Risco , Combinação Trimetoprima e Sulfametoxazol/farmacologiaRESUMO
Introducción: La terapia antibiótica, muchas veces empírica, es el eje fundamental del tratamiento de las infecciones del tracto urinario. Esto hace necesario conocer la flora bacteriana local y su patrón de resistencia para optimizar el tratamiento. Objetivo: Determinar frecuencia y resistencia de microorganismos en cultivos urinarios de pacientes adultos ambulatorios y pacientes críticos de nuestro medio hospitalario. Materiales y Método: Se realizó un estudio descriptivo retrospectivo de los urocultivos del año 2007 del Hospital Dr. Gustavo Fricke. Se utilizaron frecuencias, porcentajes, y prueba de Ji2 o Fisher para el análisis de los datos. Resultados: Se obtuvo un total de 11185 urocultivos, resultando 3500 positivos (31,29 por ciento), y de éstos 1247 polimicrobianos (39,06 por ciento). Se obtuvo 830 muestras correspondientes a pacientes ambulatorios, siendo el microorganismo más frecuentemente aislado Escherichia coli (Ec) (72,53 por ciento) seguido por Klebsiella pneumonías (Kp) (5,78 por ciento). Ec presenta una resistencia de 20,43 por ciento a ciprofloxacino, 49,5 por ciento a ampicilina, y 29 por ciento a cotrimoxazol. Se obtuvo 129 urocultivos correspondientes a unidades de pacientes críticos, aislándose más frecuentemente Ec (24,03 por ciento), Kp (20,93 por ciento), Candida albicans (16,28 por ciento) y Pseudomonas aeruginosa (13,95 por ciento). Se encontró una diferencia significativa al comparar las frecuencias de cada microorganismo entre pacientes ambulatorios y críticos (p=0,001), y al comparar los patrones de resistencia de Ec para diferentes antibacterianos entre ambos grupos. Conclusiones: La microbiología se ajusta a lo descrito en la literatura, aunque se observa mayor resistencia por parte de Ec a antimicrobianos de uso común en nuestro medio. Se observan además poblaciones microbiológicas diferentes entre el medio ambulatorio y el de pacientes críticos.
The antibiotic therapy, often empirical, is the fundamental axis in treatment of urinary tract infections. This makes necessary to know the local bacterial flora and its pattern of resistance to optimize the treatment. Aim: To determine the frequency and resistance of microorganisms in urinary cultures of adult ambulatory patients and critical units patients of our hospital. Materials and method: We conducted a descriptive retrospective study of the urinary cultures of 2007 at Dr. Gustavo Fricke Hospital. Frequencies, percentages, and 312 or Fisher test the data analysis. Results: A total of 11185 urinary cultures was obtained, with 3500 positives (31,29 per cent), and of these 1247 polymicrobial (39,06 per cent). There were 830 samples corresponding to ambulatory patients, and the most frequently isolated microorganism was Escherichia coli (Ec) (72,53 per cent) followed by klebsiella pneumoniae (Kp) (5,78 per cent). Ec presents a resistance of 20,43 per cent to ciprofloxacine, 49,5 per cent to ampicillin, and 29 per cent to cotrimoxazole. There were 129 urinary cultures from critical care patients, isolating more frequently Ec (24,03 per cent), Kp (20,93 per cent), Candida albicans (16,28 per cent) and Pseudomonas aeruginosa (13,95 per cent). There was a significant diffence when comparing the frequencies of every microorganism among ambulatory and critical units patients (p=0,001), and when comparing the pattern of drug resistence of Ec for different antibacterial agents between both groups. Conclusions: The microbiology of this sample adjusts to that described in the literature, although higher resistance is observed of Ec to antimicrobial agents of common use in our hospital. Microbiological different populations are observed among the ambulatory and critical units patients.
Assuntos
Humanos , Antibacterianos , Doenças Urológicas/complicações , Infecções por Escherichia coli/microbiologia , Microbiologia , Ampicilina/farmacologia , Ciprofloxacina/farmacologia , Cuidados Críticos/estatística & dados numéricos , Pacientes Ambulatoriais/estatística & dados numéricosRESUMO
OBJETIVO: Determinar la resistencia del uropatógeno comunitario más frecuente, Escherichia coli, a diversos antimicrobianos y deducir opciones de manejo empírico. MATERIAL Y MÉTODOS: Del 14 de julio de 2005 al 13 julio de 2006 se estudiaron cepas de Escherichia coli aisladas de urocultivos de pacientes que asistieron a la consulta externa de la Clínica Nova y del Hospital San José, en Monterrey, Nuevo León, México. Se identificó la bacteria y se determinó susceptibilidad a antibióticos mediante método automatizado. Se compararon los resultados entre las dos instituciones y la frecuencia de resistencia a antimicrobianos entre mujeres de entre 15 a 50 años de edad y > 50. RESULTADOS: Se analizaron 652 urocultivos: 303 (46.5 por ciento) de Clínica Nova y 349 (53.5 por ciento) del Hospital San José. Las cepas aisladas fueron resistentes a ampicilina, en 67.2 por ciento; a trimetoprim-sulfametoxazol, en 59.2 por ciento; a cefazolina, en 35.6 por ciento, y a ciprofloxacino, en 24.7 por ciento. CONCLUSIONES: La resistencia a trimetoprim-sulfametoxazol y ciprofloxacino, considerados de elección en el manejo empírico de las infecciones de vías urinarias adquiridas en la comunidad, es alta. Las opciones de manejo son pocas.
OBJECTIVE: Determine antibiotic resistance of community-acquired uropathogen Escherichia coli and infer therapeutic options. MATERIAL AND METHODS: E. coli strains isolated from urine during a one-year period were studied. Identification and susceptibility tests were performed. RESULTS: A total of 652 isolates were included from patients in two institutions, a healthcare clinic 303 (46.5 percent) and a hospital 349 ( 53.5 percent). The antimicrobials with higher resistance rates were ampicillin 67.2 percent, trimethoprim-sulfametoxazole 59.2 percent, cefazolin 35.6 percent and ciprofloxacin 24.7 percent. CONCLUSIONS: Resistance to trimethoprim-sulfamethoxazole and ciprofloxacin used for empiric treatment in community urinary infections is high, and there are few available treatment options.
Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/microbiologia , Farmacorresistência Bacteriana Múltipla , Infecções por Escherichia coli/microbiologia , Escherichia coli/efeitos dos fármacos , Instituições de Assistência Ambulatorial/estatística & dados numéricos , Ampicilina/farmacologia , Antibacterianos/farmacologia , Cefazolina/farmacologia , Ciprofloxacina/farmacologia , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/epidemiologia , Infecções por Escherichia coli/tratamento farmacológico , Infecções por Escherichia coli/epidemiologia , Escherichia coli/genética , Hospitais Privados/estatística & dados numéricos , México/epidemiologia , Combinação Trimetoprima e Sulfametoxazol/farmacologiaRESUMO
In this study we use 20 sheep divided into four groups [one group was injected with the vaccine, the second was taken the vaccine and ampicillin, the third group was taken the vaccine and cephalosporin and the fourth act as a control]. The immunity was measured humoral immunity to sheep pox virus vaccine by neutralization test and cell mediated immunity by lymphocyte transformation assay as well as phagocytosis. The results revealed that an increase of the immune status in group injected with antibiotics with vaccine than that received the vaccine only and than the control group. There were an increase of lymphocyte transformation test, neutralization test and phagocytosis. It could be concluded that ampicillin and cephalosporin directly increase the immune status in sheep vaccinated with sheep poxvirus vaccine
Assuntos
Animais , Imunomodulação/efeitos dos fármacos , Ampicilina/farmacologia , Cefalosporinas/farmacologia , Capripoxvirus/imunologia , Vacinas Virais , Transformação Celular Viral/efeitos dos fármacos , Colorimetria/métodosRESUMO
Presentar nuestra experiencia en 18 colecistectomías laparoscópicas con un sólo puerto visible subxifoideo de 5 mm, obtenida en el Departamento de Cirugía de dos hospitales privados, con el fin de introducir en nuestro país las técnicas que disminuyan aún más el trauma de la laparoscopia tradicional. Estudio prospectivo, observacional. Fueron intervenidos 18 pacientes con la técnica de colecistectomía laparoscópica con un sólo puerto visible subxifoideo, en el período de enero a abril de 2008. Se excluyeron casos de colecistitis aguda, coledocolitiasis y cáncer. Se analizaron la edad, sexo, el tiempo quirúrgico, la estancia hospitalaria, las complicaciones, el índice de conversión y los efectos estéticos. Predominó el sexo femenino (17 a 1). La edad promedio fue de 41 años. El tiempo quirúrgico promedio fue de 67 minutos (58 minutos promedio con el uso del ligasure y 98 minutos sin este equipo). El tiempo de hospitalización fue de 24 horas. Se evidenció una sola cicatriz a nivel subxifoideo, en contraste con la técnica laparoscópica habitual, con 3 cicatrices visibles. No hubo conversiones. No hubo morbilidad ni mortalidad. La técnica es perfectamente reproducible en nuestro medio, aportando beneficios adicionales estéticos a la colecistectomía laparoscópica tradicional.
Assuntos
Humanos , Masculino , Adulto , Feminino , Ampicilina/administração & dosagem , Colecistectomia Laparoscópica/métodos , Cálculos da Bexiga Urinária/complicações , Cálculos da Bexiga Urinária/diagnóstico , Ampicilina/farmacologia , Processo Xifoide/cirurgia , Ducto Cístico/cirurgiaRESUMO
Antimicrobial sensitivity tests were carried out on Escherichia coli, Shigella sp, Salmonella sp, and Proteus mirabilis using standard procedures. Significant differences (p < 0.01) were seen in the effect of the antimicrobial agents (garlic, ciprofloxacin and ampicillin), and in the sensitivities of the microbial species (p < 0.01) to the antimicrobial agents were observed. The gram-negative diarrheagenic pathogens from the stool samples were highly sensitive to garlic, while ciprofloxacin (CPX) was most effective against E. coli. The differences were inferred to result from genetic differences among the organisms and differences in the modes of action of the antibiotics. No isolates were resistant to garlic, making it a promising antimicrobial agent. It appears that antibiotics that interfere with DNA and RNA syntheses, such as garlic does, could constitute an effective partner in the synergic effect of garlic currently being investigated worldwide.
Assuntos
Ampicilina/farmacologia , Análise de Variância , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Ciprofloxacina/farmacologia , Diarreia/microbiologia , Enterobacteriaceae/efeitos dos fármacos , Fezes/microbiologia , Alho , Humanos , Testes de Sensibilidade Microbiana , Plantas MedicinaisRESUMO
A 16-year-old adolescent presented with fever, lethargy and vomiting associated with mild dehydration. This was followed less than 24-hours later by loss of consciousness, seizures and clinical brain death. She had no prior medical illness, no hospital or frequent antibiotic exposure. There was no evidence of soft tissue or skin infection. Management included intravenous fluids, ampicillin and cefotaxime parenterally, dexamethasone, endotracheal intubation and mechanical ventilation. Her neurologic examination remained unchanged with areflexia, flaccid paralysis and fixed pupils. Post-mortem examination revealed an eight-centimetre right fronto-parietal lobe brain abscess. Cultures were positive for methicillin resistant Staphylococcus aureus. Although formerly a nosocomial pathogen affecting debilitated patients in the hospital setting, S aureus that is methicillin resistant is emerging as a community acquired pathogen affecting previously well patients.
Una adolescente de 16 años de edad se presentó con fiebre, letargia y vómitos, asociados con deshi-dratación ligera. Estos síntomas fueron seguidos en menos de 24 horas por pérdida de conciencia, ataques y muerte clínica del cerebro. Con anterioridad, la paciente no había tenido enfermedad médica, ni hospitalización, ni tratamiento frecuente con antibióticos. No había evidencia de tejidos blandos o infección de la piel. El tratamiento incluyó líquidos intravenosos, ampicilina y cefotaxima de forma parenteral, dexametasona, entubación endotraqueal, y ventilación mecánica. El examen neurológico permaneció invariable con areflexia, parálisis flácida, y pupilas fijas. El examen post-mortem reveló un absceso cerebral de ocho centímetros en el lóbulo fronto-parietal derecho. Los cultivos resultaron positivos al Staphylococcus aureus resistente a la meticilina. Aunque visto an-teriormente como un patógeno nosocomial que afecta a los pacientes debilitados en el entorno hos-pitalario, el S aureus resistente a la meticilina está surgiendo como un patógeno extrahospitalario (ie adquirido en la comunidad) y afecta a pacientes previamente sanos. 1Equivalente acuñado aquí para el término inglés caseness, a saber, criterios que definen el estatus de caso sobre la base de la presencia de sintomatologia clinicamente significativa.
Assuntos
Humanos , Feminino , Adolescente , Abscesso Encefálico/microbiologia , Infecções Comunitárias Adquiridas/complicações , Infecções Estafilocócicas/complicações , Resistência a Meticilina , Staphylococcus aureus/isolamento & purificação , Abscesso Encefálico/diagnóstico , Ampicilina/farmacologia , Ampicilina/uso terapêutico , Cefotaxima/farmacologia , Cefotaxima/uso terapêutico , Evolução Fatal , Infecções Comunitárias Adquiridas/microbiologia , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/efeitos dos fármacosRESUMO
Enterococcus faecalis isolates were examined by an automated identification and susceptibility system. Almost all of the 97 isolates were ampicillin susceptible (n = 86) and tetracycline resistant (n = 89). All were nitrofurantoin susceptible. About a third of isolates showed high level resistance to the aminoglycosides streptomicin and gentamicin and this was usually associated with ciprofloxacin resistance (n = 34). Seven isolates were vancomycin resistant, including one that was ampicillin resistant. Most forms of resistance described elsewhere were found.
Aislados de enterococcus faecalis fueron examinados mediante un sistema automatizado de identificación y susceptibilidad. Casi todos los 97 aislados examinados fueron susceptibles a la ampi-cilina (n = 86) y resistentes a la tetraciclina (n = 89). Todos fueron susceptibles a la nitrofurantoína. Alrededor de una tercera parte de los aislados mostró un alto nivel de resistencia a los aminoglicósidos, por regla general asociada con la resistencia a la ciprofloxacina (n=34). Siete aislados resultaron resistentes a la vancomicina, incluyendo uno que fue resistente a la ampicilina. Se encontraron la mayoría de las formas de resistencia descritas en otras partes.
Assuntos
Humanos , Antibacterianos/farmacologia , Enterococcus faecalis/efeitos dos fármacos , Hospitais Universitários/estatística & dados numéricos , Infecção Hospitalar/microbiologia , Infecções por Bactérias Gram-Positivas/microbiologia , Nitrofurantoína/farmacologia , Farmacorresistência Bacteriana , Ampicilina/farmacologia , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Infecções por Bactérias Gram-Positivas/epidemiologia , Infecções por Bactérias Gram-Positivas/prevenção & controle , Jamaica , Testes de Sensibilidade Microbiana , Tetraciclina/farmacologiaRESUMO
PURPOSE: Recent reports indicate decreased susceptibility of S. typhi to fluoroquinolones, especially ciprofloxacin. Chloramphenicol has been suggested as first line therapy of enteric fever in many studies. This is a prospective study that describes the trends of antimicrobial susceptibility of S. typhi and S. paratyphi A causing bacteraemia in children and reports therapeutic failure to ciprofloxacin and evaluates the possible use of chloramphenicol, ampicillin, ciprofloxacin and third generation cephalosporins as first line therapy in the treatment of enteric fever in children. METHODS: The present study was conducted from April 2004 to March 2005 in a superspeciality children hospital at New Delhi. A total of 56 S. typhi and five S. paratyphi A isolates were obtained among the 673 blood cultures performed. Antimicrobial testing was done using disk diffusion technique (NCCLS method) for 13 antimicrobials and MICs were calculated for ampicillin, ciprofloxacin, chloramphenicol and cefotaxime. Analysis of data was done using WHONET software. RESULTS: All 56 isolates of S. typhi were sensitive to amoxycillin+clavulanate, gentamicin, cefixime, cefotaxime and ceftazidime. Multidrug resistance (MDR, resistance to three drugs) was seen in 22 cases (39%) and resistance to five drugs was seen in 12 cases (21%). Only two isolates were resistant to chloramphenicol (3%). MIC 90 for ampicillin, chloramphenicol, ciprofloxacin and cefotaxime were 1.0 microg/ml, 4.0 microg/ml, 64 microg/ml and 0.125 microg/ml respectively. All S. paratyphi A isolates were sensitive to ampicillin and chloramphenicol and resistant to nalidixic acid. MIC distribution data for chloramphenicol revealed elevated MIC but still in susceptible range. CONCLUSIONS: There is an urgent need for further clinical studies to evaluate response to chloramphenicol in such cases. Antimicrobial susceptibility data and MIC distribution favour use of ampicillin as a drug of choice for the treatment of enteric fever. Third generation cephalosporins are also useful but their use should be restricted for complicated cases.
Assuntos
Ampicilina/farmacologia , Antibacterianos/farmacologia , Bacteriemia/tratamento farmacológico , Sangue/microbiologia , Cefalosporinas/farmacologia , Criança , Pré-Escolar , Cloranfenicol/farmacologia , Meios de Cultura , Farmacorresistência Bacteriana , Humanos , Testes de Sensibilidade Microbiana , Salmonella paratyphi A/efeitos dos fármacos , Salmonella typhi/efeitos dos fármacos , Febre Tifoide/tratamento farmacológicoRESUMO
The objective of this study was to evaluate the demographic data and clinical presentation of childhood shigellosis, and to study the microbiological data and antimicrobial susceptibilities of Shigella spp. Nine thousand nine hundred fourteen stool culture specimens from children aged 0-15 years who were treated at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, between 1996 and 2000 were retrospectively reviewed. Data were collected from microbiological records and medical charts of childhood shigellosis in terms of demographic data, symptoms, signs, and complications of the patients, and the species and antimicrobial susceptibilities of the organisms. The data were analyzed in terms of means, ranges, and percentages. Of 1,523 children whose stool cultures were positive for pathogenic bacteria, 80 (5.3%) were infected with Shigella spp; 34 females and 46 males. The age distribution ranged from 1 day to 13 years with a mean age of 3.6 years. Common clinical presentations included diarrhea (96.6%), fever (77.6%) and vomiting (44.8%); seizures were the most common complication found (27.6%). Watery and mucous were the most common characteristics of stools. The major Shigella spp found was S. sonnei (62.8%), which was susceptible to co-trimoxazole, ampicillin, cefazolin and ciprofloxacin in 2.3, 84.1, 100 and 100%, respectively. A short course of quinolones or oral cephalosporins should be recommended for the treatment of childhood shigellosis in areas with low susceptibility rates to co-trimoxazole and ampicillin.